title: Digital Ulcers, Systemic Sclerosis Sine Scleroderma and Paraneoplastic Phenomena Responding to Bosentan Therapy.
authors.forename: Itzhak
authors.initials: I
authors.lastname: Sharabi
authors.forename: Amir
authors.initials: A
authors.lastname: Tanay
authors.forename: Gisele
authors.initials: G
authors.lastname: Zandman-Goddard
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000503:physiopathology; D000368:Aged; D044963:Biopsy, Fine-Needle / Q000379:methods; D000077300:Bosentan; D003937:Diagnosis, Differential; D065128:Endothelin Receptor Antagonists / Q000008:administration & dosage; D005260:Female; D005385:Fingers / Q000473:pathology*; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000503:physiopathology; D009367:Neoplasm Staging; D010257:Paraneoplastic Syndromes / Q000175:diagnosis / Q000503:physiopathology; D011013:Pneumonectomy / Q000379:methods; D012595:Scleroderma, Systemic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D012698:Serologic Tests / Q000379:methods; D012883:Skin Ulcer / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D013449:Sulfonamides / Q000008:administration & dosage*; D020775:Thoracic Surgery, Video-Assisted; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D065128:Endothelin Receptor Antagonists; D013449:Sulfonamides; D000077300:Bosentan